Land: Schweiz
Sprache: Deutsch
Quelle: Swissmedic (Swiss Agency for Therapeutic Products)
olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum
Mylan Pharma GmbH
C09DX03
olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum
Filmtabletten
Filmtablette: olmesartanum medoxomilum 40 mg, amlodipinum 10 mg ut amlodipini besilas, hydrochlorothiazidum 25 mg, povidonum K 30, amylum pregelificatum, cellulosum microcristallinum silicificatum, lactosum monohydricum 20 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto.
B
Synthetika
Hypertonie
zugelassen
2022-09-23